Potassium Lactate

Summary

Potassium Lactate (CHEMBL1200664) is an approved small molecule (ATC B05XA15).

At a glance

• Status: Approved (max clinical phase 4)
• Modality: Small molecule
• ATC class: B05XA15
• Chemistry: 128.17 Da · C3H5KO3

Identifiers

Drug identity and classification

Field	Value
ChEMBL ID	CHEMBL1200664
Name	Potassium Lactate
Type	Small molecule
Max phase	4
FDA approved	no
PubChem CID	23671663
ATC	B05XA15
Molecular formula	C3H5KO3
Molecular weight	128.17
InChIKey	PHZLMBHDXVLRIX-UHFFFAOYSA-M

SMILES: CC(C(=O)[O-])O.[K+]

IUPAC name: potassium 2-hydroxypropanoate

Also known as: E-326, E326, INS NO.326, INS-326, Lactic acid, monopotassium salt, potassium salt, Monopotassium lactate, Potassium lactate, Potassium lactate (solution), POTASSIUM LACTATE, Potassium Lactate

Patent coverage: 3,179 distinct patent families (9,220 SureChEMBL compound mentions), from 1 matched compound structure(s). Mentions count patents naming the compound (not distinct inventions), so promiscuous / reference molecules inflate the mention figure — families are the dedup metric.

Targets

Targets

No target linkage available.

Bioactivity

No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).

Target pathways

No target-pathway data for this drug (no mapped target genes).

Indications & clinical

Indications

0 indication records carry no mapped disease name (EFO/MeSH-only); none shown.

Clinical trials

Total trials: 0.

Clinical evidence (CIViC)

No CIViC predictive evidence (expected for non-precision-medicine drugs).

Pharmacology

Pharmacogenomics

No PharmGKB pharmacogenomic data curated for this drug.

Related molecules

Related molecules

No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).